Physician profile
Cosmo Haralambidis
NPI 1790819985
$1,510.81
in general payments reported to CMS, 2019-2025
7 companies · $385 in 2025
The $385 reported for 2025 was more than what 75% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
See the full distribution for Orthodontics and Dentofacial Orthopedics
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.00 · 2020: $275 · 2021: $95.10 · 2022: $41.48 · 2023: $172 · 2024: $492 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $927 · Gift: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $926.87 |
| Gift | $121.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $574.72 | 2020-2024 | Invisalign, Itero Element 5d |
| American Orthodontics Corporation | $386.57 | 2019-2025 | Master Series, Empower-Metal, LP and Ifit Tubes |
| USA Angelalign Technology Corp | $287.00 | 2024-2025 | |
| Ormco Corporation | $95.28 | 2020 | |
| Solventum Corporation | $88.81 | 2024-2025 | 3m, Clarity Aligners |
| Zimvie INC. | $61.95 | 2024 | |
| Straumann USA LLC | $16.48 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cosmo Haralambidis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.